PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Broussonetia papyrifera polysaccharide (BPP) protected against liver injury, alleviated apoptosis, and improved antioxidant capacity and detoxification, potentially mediated by intestinal flora [PMID: 35807816].
Total flavonoids (TFBP) significantly decreased lipid accumulation in HepG2 cells and decreased total cholesterol, triglycerides, and LDL-C while increasing HDL-C in serum [PMID: 38649009].
B. papyrifera pollen is identified as an important cause of allergic rhinitis in Southwest China [PMID: 36165984] and is associated with asthma exacerbations in Islamabad [PMID: 37651635, 38306347].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 37978431 (2023) — Induction of tetraploids in Paper Mulberry (Broussonetia papyrifera (L.) L'Hér. ex Vent.) by colchicine. · BMC plant biology
- 2.PMID: 27529483 (2016) — Sex Distribution of Paper Mulberry (Broussonetia papyrifera) in the Pacific. · PloS one
- 3.PMID: 39451520 (2024) — Identification of the Optimal Quantitative RT-PCR Reference Gene for Paper Mulberry (Broussonetia papyrifera). · Current issues in molecular biology
- 4.PMID: 33838656 (2021) — First comprehensive analysis of lysine succinylation in paper mulberry (Broussonetia papyrifera). · BMC genomics
- 5.PMID: 36165984 (2022) — Broussonetia papyrifera (paper mulberry) pollen is an important cause of allergic rhinitis in Southwest China.